Clinical Trial Update: Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pre-operative targeted therapies for patients with molecularly selected resectable colorectal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Gruppo Oncologico del Nord-Ovest | Conditions: Colorectal Cancer, Resectable Colorectal Carcinoma | Phase 2 | Status: RECRUITING